Inside the Munich Re Paradox: Record Underwriting Meets Market Doubt as €2.25bn Buyback Kicks Off

Despite a stellar 66.8% combined ratio, €1.7bn profit, and €5.3bn capital return, Munich Re shares hover near 52-week low amid pricing pressure and currency headwinds.

Munich Re’s first-quarter numbers tell a story of near flawless execution — yet investors remain unmoved. The world’s largest reinsurer posted underwriting results that would make most peers envious, while its shares hover just above a 52-week low. The disconnect has become the defining narrative for the Munich-based group.

The stock traded at €474 on Friday, up 1.17%, but that gain leaves it barely 1% above the year’s trough of €467.30. Since the start of the year, the shares have shed 13.66%, and the 30-day slide stands at 15.81%. With the 200-day moving average a full 11.83% higher, technical damage is evident.

Underwriting That Raises Eyebrows

At the heart of the quarterly report is a combined ratio of just 66.8% in the property-casualty reinsurance segment. For every euro of premium income, Munich Re spent less than 67 cents on claims and administration — an unusually tight performance by any standard. The investment result came in at nearly €1bn, while IFRS equity climbed to €34.6bn.

The primary insurance subsidiary ERGO contributed €235m to group net income. Overall, the group delivered net profit of €1.7bn for the first quarter, keeping it on track to hit the full-year target of €6.3bn.

Capital Strength That Fuels Payouts

Munich Re’s solvency ratio under Solvency II dipped slightly from 298% to 292%, but remains far above regulatory thresholds. That ample capital buffer underpins an aggressive shareholder return policy. For the 2025 financial year, the company paid a dividend of €24.00 per share, and the broader capital return — dividend plus buyback — totals roughly €5.3bn.

The current €2.25bn share repurchase program, which runs through the 2027 annual general meeting on April 29, 2027, is now in motion. The first tranche, worth up to €900m, began on May 14, 2026, and is scheduled to run no later than August 21, 2026. It represents around 1.5% of the company’s share capital. Banks are handling the timing and volume independently, with the group taking no role in individual trading decisions. Shares bought back will be cancelled.

Insiders Put Their Money Where the Stock Is

Board members have been buying shares on their own account. On May 12, Dr. Achim Kassow and Stefan Golling acquired Munich Re stock via the XETRA electronic trading platform. Earlier, Dr. Markus Rieß purchased shares worth approximately €238,251 at an average price of €476.50. While insider buying is no guarantee of a turnaround, it signals that parts of management are willing to commit personal capital at these levels.

The Elephant in the Room: Pricing Pressure

For all the operational strength, the market remains focused on the pricing environment in reinsurance. Risk-adjusted premiums declined by 3.1% in the quarter, a sign of intensifying competition that could squeeze future margins. Currency effects also hit revenues hard: group insurance revenue fell by almost €800m to €15bn, largely because many reinsurance contracts are dollar-denominated and the exchange rate moved against Munich Re.

The contrast with the group’s own forecasts is stark. Management continues to target consolidated insurance revenue of around €64bn for 2026 and net profit of about €6.3bn. By 2030, Munich Re aims for average annual profit growth of 8%. At a price-to-earnings ratio of roughly 10x current-year earnings, the valuation appears cheap — if the earnings trajectory holds.

What Needs to Change

The next major test comes in July with the July 1 renewal season. Munich Re expects broadly stable pricing, which would remove a key source of skepticism. Should the pricing picture stabilize, the buyback, insider purchases, and profit targets would align more convincingly with the depressed share price.

Until then, the stock trades near €473 — roughly 22% below its 52-week high of €605. The relative strength index of 72 signals short-term overbought conditions after the modest bounce, adding a technical caveat to any bullish case. For a sustained recovery, the market will need to see that the combined ratio strength is not a one-off and that catastrophe claims remain within statistical norms over the coming quarters.